ABSTRACT BACKGROUND Urinary tract infection in pregnancy is one of the most common bacterial infections, which if not treated can cause serious harm to both mother and foetus. A woman is predisposed to urinary tract infection because of the close proximity to vagina and anus, in addition to low immunity during pregnancy. Timely intervention in the form of appropriate screening and treatment can reduce the morbidity. This review discusses the underlying pathophysiology of urinary tract infection in pregnancy and clinical guidelines regarding the use of different medications for prevention and treatment of urinary tract infection in pregnancy.

Low immunity also plays an important role.
In patients suffering from Diabetes Type 1, patients suffer from asymptomatic bacteriuria if they have longstanding DM in addition to peripheral neuropathy and microalbuminuria, which gets on and off reactivated in case of low immunity.
In patients having Type 2 DM. there is a history of recent symptomatic UTI and neuropathy involving the urinary tract in addition to dysfunctional voiding and urinary retention. These patients are usually of higher age and they also have microalbuminuria.  If patient is suffering from dysfunctional voiding, she is prone for recurrent UTIs.  Patients having problems like voluntary withholding of urine, detrusor instability, dyssynergistic sphincter, there is disruption in laminar urine flow and bacteria get transferred back from the meatus to the bladder (Milk Back Phenomenon), they also have recurrent UTIs.
Why Pregnant Women are at Increased Risk for Urinary
Tract Infection (1, 2) In addition to the above risk factors for UTI in women in general there are anatomical and physiological changes in pregnancy which makes the pregnant women more prone for UTI, especially upper urinary infection- The kidneys become larger, there is dilatation of the renal calyces and ureter.  In pregnancy from 6 weeks to 22 -24 weeks (peak), almost 90% women develop ureteral dilatation because of progesterone-induced relaxation of the muscular layers, which remain until delivery. More marked dilatation is apparent beginning in mid-pregnancy, because of ureteral compression, especially on the right side (Faundes and associates, 1998). Then there is increased bladder volume, increased urinary stasis, decreased bladder tone, decreased ureteral tone which leads to development of ureterovesical reflux which increases chances of UTI. 
Acute Urethritis or Acute Urethral Syndrome (3)
Usually caused by one of the three organisms: Coliforms, (Principally E. coli), N. gonorrhoeae and C. trachomatis. Coliform organisms are part of normal vaginal and perineal flora and may be introduced into the urethra during intercourse or when wiping after defecation. N. gonorrhoeae and C. trachomatis are sexually transmitted pathogens.
Signs and Symptoms
Patients typically experienced frequency, urgency and dysuria. Hesitancy, dribbling and a mucopurulent urethral discharge also may be present. 
Asymptomatic Bacteriuria
Significant bacteriuria may exist in asymptomatic patients.
Prevalence in Pregnancy
2-10%, (4, 5) therefore routine screening in pregnancy is advised.
Definition
Two consecutive voided urine specimens with isolation of the same bacterial strain in quantitative counts of ≥ 10 ^5 colony forming units (cfu)/mL or a single catheterised urine sample with one bacterial species isolated in a quantitative count of ≥10^2 cfu/mL in asymptomatic women. (6, 7) In clinical practice, usually one voided urine specimen is typically obtained.
Follow-Up
Due to upto 30% chance of persistence of infection; follow-up culture is done one week after the antibiotics course and monthly cultures are preferred throughout pregnancy due to the risk of persistence of infection or recurrence. ( Acute Cystitis: Incidence is 1 -2% Acute cystitis is to be distinguished from asymptomatic bacteriuria by the presence of symptoms like sudden-onset dysuria, urgency and frequency where the patients are afebrile and there is no evidence of systemic illness. It is seen that 30% of untreated asymptomatic bacteriuria patients later developed symptomatic cystitis. Diagnosis is by urinalysis, wherein usually there is a picture of haematuria and pyuria.
Treatment of Acute Cystitis (7)
Generally, treatment of pregnant patients with acute cystitis is initiated empirically before the results of the culture. Preferably, regarding, choice of antibiotic one should try to focus on coverage of common pathogens and can be changed once the organism is identified. Different antibiotic regimens have similar efficacy and complications are rare. A 3 to 7 days course of antibiotics is given in the absence of symptoms of pyelonephritis. Available data shows no difference between short and long antibiotic courses. ( Few important points to remember like short courses of antimicrobial therapy can be considered, but there can be a high recurrence rate with serious consequences. Among the antibiotics Penicillins, Cephalosporins or Fosfomycin can be considered. The drug Nitrofurantoin even though safe, cannot be given in G6P deficiency and at the end of pregnancy for the risk of haemolytic anaemia in newborn. Trimethoprim and sulphonamides not in 1 st trimester as there is a risk of congenital malformations. Sulphonamides are also avoided immediately prior to delivery, because of concern about displacement of bilirubin from protein binding sites resulting in neonatal jaundice. (3) Therapy should be 3 -7 days course and follow-up as in asymptomatic bacteriuria.
Recurrent Cystitis
In addition to the antibiotic treatment, antimicrobial prophylaxis throughout the duration of pregnancy is preferred. Prophylaxis can be continuous or postcoital depending on how the patient presents. The preferred drug and doses are 50 -100 mg Nitrofurantoin/ 250 -500 mg Cephalexin HS daily.
Pyelonephritis
It is a serious systemic illness during pregnancy with an incidence of 0.5 -2% of pregnant women, (11, 12, 7) (Upto 23% of these pregnant women have a recurrence during the same pregnancy). Pyuria is a typical finding. Most cases of pyelonephritis occur during the second and third trimesters. Pregnant women may become quite ill and are at risk for both medical and obstetrical complications from pyelonephritis. As many as 20 percent of women with severe pyelonephritis develop complications that include septic shock syndrome or its variants such as acute respiratory distress syndrome.
Category Finding

History
Lower urinary tract symptoms (e.g. frequency, urgency, dysuria), Upper urinary tract symptoms (e.g. flank pain), constitutional symptoms (e.g. nausea, vomiting, anorexia, abdominal pain). 
Diagnosis (By Other Modalities)
Severe cases patients might need a renal ultrasonography or may be an abbreviated intravenous pyelogram. IV pyelogram is indicated in persistent infection after appropriate antibiotic therapy when there is a suspicion of structural abnormality, which is not seen on USG. But the low dose radiation involved can be dangerous to foetus, so long as one should try to avoid. 
Maternal Complications of Pyelonephritis
Treatment of Pyelonephritis (2)
Patient should be treated aggressively, which is important for preventing complications. Fluoroquinolones and aminoglycosides should be avoided in pregnancy, if possible. Otherwise, they are very effective for pyelonephritis in nonpregnant individuals. ( 
UTI because of Group B Streptococcal Infection (GBS Infection)
Group B Streptococcal vaginal colonisation is the root cause for neonatal sepsis. It is associated with preterm rupture of membranes, pre-term labour and delivery. Incidence of GBS in pregnancy-5%. The evidence that GBS bacteriuria increases risk of premature rupture of membranes or preterm labour is mixed. An RCT report conducted showed that there is significant reduction in rates of PROM and preterm labour in women who received antibiotics. All pregnant women with GBS bacteriuria should be treated as GBS carriers and should receive a prophylactic antibiotic during labour.
